ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1234
First IPO Date
August 19, 2011
| Name | Title | Pay | Year Born |
| Junxian Yu | Secretary, Vice President & Non-Independent Director | 0 | 1967 |
| Ying Min Yu | Chief Engineer | 0 | 1963 |
| Ya Li Liu | Chief Accountant | 0 | N/A |
| Han Yin | Vice President | 0 | 1982 |
| Yanjie He | Financial Director | 0 | 1982 |
| Qun Zhao | President & Director | 0 | 1971 |
| Kai Rui Luo | Vice President | 0 | 1976 |
| Bao Ping Gu | Vice President | 0 | 1972 |
ShanXi C&Y Pharmaceutical Group Co., Ltd. is a global pharmaceutical enterprise dedicated to the research, development, production, and distribution of a diverse range of medicines. Its operations span key markets including China, the United States, and Hong Kong, alongside other international regions. The company's extensive product catalog features specialized solutions for maternal and infant care, urological health, and infectious diseases, as well as traditional Chinese remedies and dermatological treatments. Additionally, it diversifies its offerings with tea bag products. Founded in 2005, the organization underwent a name change in September 2014, evolving from Shanxi C&Y Pharmaceutical Co., Ltd. to its current designation. ShanXi C&Y Pharmaceutical Group Co., Ltd. maintains its corporate headquarters in Shanghai, China.